NAT10 as a central node in cancer biology: integrating epitranscriptomic regulation, metabolic reprogramming, and immune modulation - Scorecard - MDSpire

NAT10 as a central node in cancer biology: integrating epitranscriptomic regulation, metabolic reprogramming, and immune modulation

  • By

  • Wentao Bo

  • Ying Yi

  • Biao Zhao

  • Hang Dong

  • June 5, 2026

  • 0 min

Share

Clinical Scorecard: NAT10: A Key Regulator in Cancer Dynamics Through Epitranscriptomic Control, Metabolic Changes, and Immune Interaction

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target Population
Care SettingSpecify the type of oncology care (e.g., clinical trials, standard treatment).

Key Highlights

  • remove

Guideline-Based Recommendations

Diagnosis

    Management

    • R
    • e
    • m
    • o
    • v
    • e
    • u
    • n
    • s
    • u
    • p
    • p
    • o
    • r
    • t
    • e
    • d
    • c
    • l
    • a
    • i
    • m
    • s
    • a
    • b
    • o
    • u
    • t
    • p
    • h
    • a
    • r
    • m
    • a
    • c
    • o
    • l
    • o
    • g
    • i
    • c
    • a
    • l
    • s
    • t
    • r
    • a
    • t
    • e
    • g
    • i
    • e
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Remove unsupported claims about enhancing treatment efficacy.

        Clinical Best Practices

        • remove

        Related Resources & Content

        Original Source(s)

        NAT10 as a central node in cancer biology: integrating epitranscriptomic regulation, metabolic reprogramming, and immune modulation

        • by Wentao Bo, Ying Yi, Biao Zhao, Hang Dong

        • June 5, 2026

        Related Content

        What do cancer patients discuss online regarding CINV management? A social media-based topic modeling study

        Beyond prediction: AI as a mechanistic microscope and digital twin for colorectal cancer immunotherapy

        Targeting mitochondria as a potential therapeutic strategy against radioresistance in cancer